X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
53
PharmaCompass offers a list of Hydrocortisone Sodium Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydrocortisone Sodium Succinate manufacturer or Hydrocortisone Sodium Succinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydrocortisone Sodium Succinate manufacturer or Hydrocortisone Sodium Succinate supplier.
PharmaCompass also assists you with knowing the Hydrocortisone Sodium Succinate API Price utilized in the formulation of products. Hydrocortisone Sodium Succinate API Price is not always fixed or binding as the Hydrocortisone Sodium Succinate Price is obtained through a variety of data sources. The Hydrocortisone Sodium Succinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cortisol Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cortisol Succinate, including repackagers and relabelers. The FDA regulates Cortisol Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cortisol Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cortisol Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cortisol Succinate supplier is an individual or a company that provides Cortisol Succinate active pharmaceutical ingredient (API) or Cortisol Succinate finished formulations upon request. The Cortisol Succinate suppliers may include Cortisol Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Cortisol Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cortisol Succinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Cortisol Succinate active pharmaceutical ingredient (API) in detail. Different forms of Cortisol Succinate DMFs exist exist since differing nations have different regulations, such as Cortisol Succinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cortisol Succinate DMF submitted to regulatory agencies in the US is known as a USDMF. Cortisol Succinate USDMF includes data on Cortisol Succinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cortisol Succinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cortisol Succinate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cortisol Succinate Drug Master File in Japan (Cortisol Succinate JDMF) empowers Cortisol Succinate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cortisol Succinate JDMF during the approval evaluation for pharmaceutical products. At the time of Cortisol Succinate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cortisol Succinate suppliers with JDMF on PharmaCompass.
A Cortisol Succinate CEP of the European Pharmacopoeia monograph is often referred to as a Cortisol Succinate Certificate of Suitability (COS). The purpose of a Cortisol Succinate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cortisol Succinate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cortisol Succinate to their clients by showing that a Cortisol Succinate CEP has been issued for it. The manufacturer submits a Cortisol Succinate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cortisol Succinate CEP holder for the record. Additionally, the data presented in the Cortisol Succinate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cortisol Succinate DMF.
A Cortisol Succinate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cortisol Succinate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cortisol Succinate suppliers with CEP (COS) on PharmaCompass.
A Cortisol Succinate written confirmation (Cortisol Succinate WC) is an official document issued by a regulatory agency to a Cortisol Succinate manufacturer, verifying that the manufacturing facility of a Cortisol Succinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cortisol Succinate APIs or Cortisol Succinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Cortisol Succinate WC (written confirmation) as part of the regulatory process.
click here to find a list of Cortisol Succinate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cortisol Succinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cortisol Succinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cortisol Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cortisol Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cortisol Succinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cortisol Succinate suppliers with NDC on PharmaCompass.
Cortisol Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cortisol Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cortisol Succinate GMP manufacturer or Cortisol Succinate GMP API supplier for your needs.
A Cortisol Succinate CoA (Certificate of Analysis) is a formal document that attests to Cortisol Succinate's compliance with Cortisol Succinate specifications and serves as a tool for batch-level quality control.
Cortisol Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Cortisol Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cortisol Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cortisol Succinate EP), Cortisol Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cortisol Succinate USP).
Market Place
